CME Price To Book vs. Number Of Shares Shorted

CME Stock  USD 208.50  6.42  2.99%   
Based on the measurements of profitability obtained from CME's financial statements, CME's profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess CME's ability to earn profits and add value for shareholders. At present, CME's Days Of Sales Outstanding is projected to increase significantly based on the last few years of reporting. At present, CME's Net Income is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 973.8 M, whereas Operating Income is forecasted to decline to about 1.8 B.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.920.8139
Moderately Up
Pretty Stable
For CME profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CME to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CME Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CME's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CME Group over time as well as its relative position and ranking within its peers.
  

CME's Revenue Breakdown by Earning Segment

Check out Trending Equities.
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Dividend Share
4.45
Earnings Share
8.79
Revenue Per Share
15.638
Quarterly Revenue Growth
0.032
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CME Group Number Of Shares Shorted vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CME's current stock value. Our valuation model uses many indicators to compare CME value to that of its competitors to determine the firm's financial worth.
CME Group is rated fourth in price to book category among related companies. It is number one stock in number of shares shorted category among related companies making about  1,390,005  of Number Of Shares Shorted per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value CME by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CME's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CME's earnings, one of the primary drivers of an investment's value.

CME Number Of Shares Shorted vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

CME

P/B

 = 

MV Per Share

BV Per Share

 = 
2.82 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

CME

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
3.92 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

CME Number Of Shares Shorted Comparison

CME is currently under evaluation in number of shares shorted category among related companies.

CME Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CME, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CME will eventually generate negative long term returns. The profitability progress is the general direction of CME's change in net profit over the period of time. It can combine multiple indicators of CME, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-55.6 M-52.8 M
Operating Income3.4 B1.8 B
Income Before Tax4.2 B4.4 B
Net Income3.2 B3.4 B
Income Tax Expense927.4 M973.8 M
Total Other Income Expense Net717.9 M753.8 M
Net Income Applicable To Common Shares3.1 B3.2 B
Net Income From Continuing OpsB2.4 B
Non Operating Income Net OtherB1.1 B
Interest Income732.2 M453.2 M
Net Interest Income-159.6 M-167.6 M
Change To Netincome87.8 M92.2 M
Net Income Per Share 8.99  9.44 
Income Quality 1.07  0.77 
Net Income Per E B T 0.78  0.56 

CME Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CME. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CME position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CME's important profitability drivers and their relationship over time.

Use CME in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.

CME Pair Trading

CME Group Pair Trading Analysis

The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your CME position

In addition to having CME in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cleaning Thematic Idea Now

Cleaning
Cleaning Theme
Compnanies producing and distributing cleaning products, supplies, and accessories. The Cleaning theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cleaning Theme or any other thematic opportunities.
View All  Next Launch
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
To fully project CME's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CME Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CME's income statement, its balance sheet, and the statement of cash flows.
Potential CME investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although CME investors may work on each financial statement separately, they are all related. The changes in CME's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CME's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.